Literature DB >> 28690486

ADULT Phenotype and rs16864880 in the TP63 Gene: Two New Cases and Review of the Literature.

Tânia Kawasaki de Araujo1, Elaine Lustosa-Mendes1, Ana P Dos Santos1, Miriam Coelho Molck1, Roberta Mazzariol Volpe-Aquino1, Vera L Gil-da-Silva-Lopes1.   

Abstract

The TP63 gene has been described in 5 overlapping limb malformation disorders, including a rare autosomal dominant ectodermal disorder named acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome. This article describes 2 patients with ectrodactyly and variable features related to ectodermal dysplasia/ADULT syndrome, and the polymorphism rs16864880 in the TP63 gene, which was not present in their parents. The role of this variant in the genesis of this condition is discussed, based upon a review of 40 cases. The results suggested that rs16864880 may not be directly related to ADULT syndrome. However, it is not possible to exclude its participation in gene interactions in the limb development pathway.

Entities:  

Keywords:  ADULT syndrome; Genotype-phenotype correlation; TP63; rs16864880

Year:  2017        PMID: 28690486      PMCID: PMC5498955          DOI: 10.1159/000470025

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  20 in total

1.  Adermatoglyphia, previously unrecognized manifestation in ADULT syndrome.

Authors:  Hiram Larangeira de Almeida; Patrícia Caspary; Rodrigo Pereira Duquia; Rowdy Meijer; Maurice van Steensel
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

2.  Acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome: report of a child with phenotypic overlap with ulnar-mammary syndrome and a new mutation in TP63.

Authors:  Anne M Slavotinek; June Tanaka; Alison Winder; Karin Vargervik; Anita Haggstrom; Michael Bamshad
Journal:  Am J Med Genet A       Date:  2005-10-01       Impact factor: 2.802

3.  Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene.

Authors:  Tuula Rinne; Emanuela Spadoni; Klaus W Kjaer; Cesare Danesino; Daniela Larizza; Marianne Kock; Kirsi Huoponen; Marja-Liisa Savontaus; Markku Aaltonen; Pascal Duijf; Han G Brunner; Maila Penttinen; Hans van Bokhoven
Journal:  Eur J Hum Genet       Date:  2006-05-17       Impact factor: 4.246

4.  Letter regarding the article: "R298Q mutation of p63 gene in autosomal dominant ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy" by Valenzise et al.

Authors:  Paul A van der Zwaag; Jan D H Jongbloed; Maarten P van den Berg; Marcel F Jonkman; J Peter van Tintelen
Journal:  Eur J Med Genet       Date:  2009-02-03       Impact factor: 2.708

5.  A novel TP63 mutation in family with ADULT syndrome presenting with eczema and hypothelia.

Authors:  W A G van Zelst-Stams; M A M van Steensel
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

Review 6.  'Double trouble': diagnostic challenges in genetic skin disorders.

Authors:  D Kiritsi; M Valari; K Mileounis; L Bruckner-Tuderman; C Has
Journal:  Br J Dermatol       Date:  2014-12-17       Impact factor: 9.302

7.  TP63 gene mutation in ADULT syndrome.

Authors:  J Amiel; G Bougeard; C Francannet; V Raclin; A Munnich; S Lyonnet; T Frebourg
Journal:  Eur J Hum Genet       Date:  2001-08       Impact factor: 4.246

8.  Cleft palate and ADULT phenotype in a patient with a novel TP63 mutation suggests lumping of EEC/LM/ADULT syndromes into a unique entity: ELA syndrome.

Authors:  Paolo Prontera; Emanuela Garelli; Ilenia Isidori; Amedea Mencarelli; Adriana Carando; Margherita Cirillo Silengo; Emilio Donti
Journal:  Am J Med Genet A       Date:  2011-10-11       Impact factor: 2.802

9.  Functional characterization of a novel TP63 mutation in a family with overlapping features of Rapp-Hodgkin/AEC/ADULT syndromes.

Authors:  Valeria Serra; Marco Castori; Mauro Paradisi; Laura Bui; Gerry Melino; Alessandro Terrinoni
Journal:  Am J Med Genet A       Date:  2011-11-08       Impact factor: 2.802

10.  Differentially Expressed Genes in EEC and LMS Syndromes.

Authors:  Wei Yin; Yaling Song; Yangge Du; Zhuan Bian
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.